Some Antisense Deal Numbers, page-5

You can find literally hundreds of posts here over the years from posters with rainbow figures on deals for 1102 and 1103 on Phase II from the likes of the above "Pfizer, Biogen", "IONIS taking over" etc etc with "hundreds of millions upfront, $1, $5 etc share prices - yet they have been not even close.

2012 - Cortendo 1103 Acromegaly Phase II $5M upfront $131M potential milestones royalties.

2008 - TEVA 1102 Multiple Sclerosis Phase II $2M upfront $100M potential milestones and royalties.

This time might always be different - but highly doubt they will deal anything here - it's all about Phase IIb 2020/21